SELLAS Life Sciences Shares Fall; Interim Trial Results on Acute Myeloid Leukemia Treatment Issued
In This Article:
SELLAS Life Sciences Group (SLS) shares fell 14% in recent Thursday trading after the company announ
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.